PharmaCyte Biotech Inc PMCB:NASDAQ

RT Quote | USD
Last | 05/21/24 EDT
2.09quote price arrow down-0.05 (-2.34%)
Volume
13,351
52 week range
1.92 - 3.23
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.14
  • 52 Week High3.23
  • 52 Week High Date06/05/23
  • 52 Week Low1.92
  • 52 Week Low Date11/20/23

Key Stats

  • Market Cap17.668M
  • Shares Out8.45M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-0.15
  • YTD % Change-3.24

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.14
  • 52 Week High3.23
  • 52 Week High Date06/05/23
  • 52 Week Low1.92
  • 52 Week Low Date11/20/23
  • Market Cap17.668M
  • Shares Out8.45M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-0.15
  • YTD % Change-3.24

RATIOS/PROFITABILITY

  • EPS (TTM)-1.61
  • P/E (TTM)-1.29
  • Fwd P/E (NTM)-6.53
  • EBITDA (TTM)-6.257M
  • ROE (TTM)-27.32%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On PharmaCyte Biotech Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
PharmaCyte Biotech, Inc. is a biotechnology company. It is focused on developing cellular therapies for cancer, diabetes, and malignant ascites based upon a cellulose-based live cell encapsulation technology known as Cell-in-a-Box. Its product candidate is referred to as CypCaps. The Cell-in-a-Box encapsulation technology potentially enables genetically engineered live human cells to be used to produce various biologically active molecules. It is advancing clinical research...
Joshua Silverman
Interim Chairman of the Board, Interim President, Interim Chief Executive Officer
Carlos Trujillo CPA
Chief Financial Officer, Director
Address
3960 Howard Hughes Parkway, Suite 500
Las Vegas, NV
89169
United States

Top Peers

SYMBOLLASTCHG%CHG
NERV
Minerva Neurosciences Inc
2.46-0.02-0.81%
EVAX
Evaxion Biotech A/S
3.57-0.15-4.03%
GLTO
Galecto Inc
0.6131-0.0228-3.5855%
ALZN
Alzamend Neuro Inc
0.6298-0.0037-0.5841%
GLYC
GlycoMimetics Inc
0.2754-0.0135-4.6729%